睿昂基因
(688217)
| 流通市值：10.82亿 | | | 总市值：10.82亿 |
| 流通股本：5585.59万 | | | 总股本：5585.59万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 189,630,100.09 | 134,790,886.33 | 64,188,221.36 | 258,211,314.47 |
| 营业收入 | 189,630,100.09 | 134,790,886.33 | 64,188,221.36 | 258,211,314.47 |
| 二、营业总成本 | 192,926,333.51 | 129,763,652.75 | 64,568,301.8 | 258,370,252.57 |
| 营业成本 | 45,358,535.96 | 33,545,031.62 | 14,347,851.26 | 69,173,437.28 |
| 税金及附加 | 1,739,761.86 | 1,201,487.84 | 568,292.86 | 2,205,475.45 |
| 销售费用 | 59,338,974.8 | 38,555,399.38 | 20,880,042.14 | 77,976,550.72 |
| 管理费用 | 40,734,119.55 | 23,691,389.01 | 13,096,212.42 | 42,924,631.59 |
| 研发费用 | 46,854,439.7 | 34,201,238.57 | 16,398,202.66 | 69,799,334.81 |
| 财务费用 | -1,099,498.36 | -1,430,893.67 | -722,299.54 | -3,709,177.28 |
| 其中:利息费用 | - | 482,358.85 | - | 828,478.71 |
| 其中:利息收入 | - | 1,726,565.36 | - | 3,809,912.74 |
| 加:公允价值变动收益 | -233,417.5 | -567,339.97 | -255,220.49 | 330,933.79 |
| 加:投资收益 | 1,781,659.3 | 1,508,089.08 | 409,122.19 | 2,680,346.22 |
| 资产处置收益 | 278,041.12 | 101,435.93 | 82,070.89 | 838,806.27 |
| 资产减值损失(新) | -654,429.15 | -689,119.2 | 322.84 | -8,883,190.79 |
| 信用减值损失(新) | -5,517,111.95 | -6,185,884.74 | -2,851,284.76 | -5,516,423.36 |
| 其他收益 | 4,059,030.2 | 3,814,669.4 | 781,246.63 | 4,220,387.35 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -3,582,461.4 | 3,009,084.08 | -2,213,823.14 | -6,488,078.62 |
| 加:营业外收入 | 286,199.36 | 276,197.9 | 330,662.48 | 192,811.12 |
| 减:营业外支出 | 69,377.15 | 64,717.95 | 61,130.05 | 3,105,478.22 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -3,365,639.19 | 3,220,564.03 | -1,944,290.71 | -9,400,745.72 |
| 减:所得税费用 | -4,913,175.71 | -2,586,485.7 | -506,937.02 | -4,595,913.49 |
| 六、净利润 | 1,547,536.52 | 5,807,049.73 | -1,437,353.69 | -4,804,832.23 |
| 持续经营净利润 | 1,547,536.52 | 5,807,049.73 | -1,437,353.69 | -4,804,832.23 |
| 归属于母公司股东的净利润 | 5,727,339.64 | 9,221,789.85 | 533,165.07 | 7,930,692.32 |
| 少数股东损益 | -4,179,803.12 | -3,414,740.12 | -1,970,518.76 | -12,735,524.55 |
| (一)基本每股收益 | 0.1 | 0.17 | 0.01 | 0.14 |
| (二)稀释每股收益 | 0.1 | 0.17 | 0.01 | 0.14 |
| 九、综合收益总额 | 1,547,536.52 | 5,807,049.73 | -1,437,353.69 | -4,804,832.23 |
| 归属于母公司股东的综合收益总额 | 5,727,339.64 | 9,221,789.85 | 533,165.07 | 7,930,692.32 |
| 归属于少数股东的综合收益总额 | -4,179,803.12 | -3,414,740.12 | -1,970,518.76 | -12,735,524.55 |
| 公告日期 | 2024-10-30 | 2024-08-30 | 2024-04-27 | 2024-04-17 |
| 审计意见(境内) | | | | 标准无保留意见 |